GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » EV-to-EBITDA

Instituto Rosenbusch (BUE:ROSE) EV-to-EBITDA : 3.76 (As of Apr. 30, 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Instituto Rosenbusch's enterprise value is ARS4,429 Mil. Instituto Rosenbusch's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ARS1,178 Mil. Therefore, Instituto Rosenbusch's EV-to-EBITDA for today is 3.76.

The historical rank and industry rank for Instituto Rosenbusch's EV-to-EBITDA or its related term are showing as below:

BUE:ROSE' s EV-to-EBITDA Range Over the Past 10 Years
Min: -94.41   Med: 7.46   Max: 94.25
Current: 3.76

During the past 13 years, the highest EV-to-EBITDA of Instituto Rosenbusch was 94.25. The lowest was -94.41. And the median was 7.46.

BUE:ROSE's EV-to-EBITDA is ranked better than
91.95% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.22 vs BUE:ROSE: 3.76

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-30), Instituto Rosenbusch's stock price is ARS88.90. Instituto Rosenbusch's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ARS13.090. Therefore, Instituto Rosenbusch's PE Ratio for today is 6.79.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Instituto Rosenbusch EV-to-EBITDA Historical Data

The historical data trend for Instituto Rosenbusch's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto Rosenbusch EV-to-EBITDA Chart

Instituto Rosenbusch Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.06 10.57 8.36 1.92 3.12

Instituto Rosenbusch Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.92 1.73 2.95 2.64 3.12

Competitive Comparison of Instituto Rosenbusch's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instituto Rosenbusch's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's EV-to-EBITDA falls into.



Instituto Rosenbusch EV-to-EBITDA Calculation

Instituto Rosenbusch's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4429.269/1178.338
=3.76

Instituto Rosenbusch's current Enterprise Value is ARS4,429 Mil.
Instituto Rosenbusch's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS1,178 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instituto Rosenbusch  (BUE:ROSE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Instituto Rosenbusch's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=88.90/13.090
=6.79

Instituto Rosenbusch's share price for today is ARS88.90.
Instituto Rosenbusch's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS13.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Instituto Rosenbusch EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Instituto Rosenbusch (BUE:ROSE) Business Description

Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.